Ceftriaxone-associated biliary pseudolithiasis in paediatric surgical patients

International Journal of Antimicrobial Agents

Volumn 25, Issue 3, 2005, Pages 256-259

  Ceran, Canan ^a,b   Oztoprak, Ibrahim ^a   Cankorkmaz, Levent ^a   Gumuş, Cesur ^a   Yildiz, Turan ^a   Koyluoglu, Gokhan ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Ceftriaxone; Cholelithiasis; Gallbladder; Pseudolithiasis

Indexed keywords

CEFTRIAXONE;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; ARTICLE; BILIARY PSEUDOLITHIASIS; BILIARY TRACT DISEASE; CHILD; CHOLELITHIASIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; ECHOGRAPHY; FEMALE; HUMAN; INCIDENCE; MALE; PEDIATRIC SURGERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SIDE EFFECT; STARVATION; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL;

EID: 14344251214     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.10.008     Document Type: Article

References (13)

1. D.M. Richards, R.C. Heel, and R.N. Brogden Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use Drugs 27 1984 469 527
2. U.B. Schaad, J. Wedgwood-Krucko, and H. Tschaeppeler Reversible ceftriaxone-associated biliary pseudolithiasis in children Lancet 17 1988 1411 1413
3. S. Gropper, C. Pigrau, and M.A. Artaza Reversible ceftriaxone-associated biliary pseudolithiasis in adults J Chemother 3 1990 268 270
4. K.L. Heim-Duthoy, E.M. Caperton, and R. Pollock Apparent biliary pseudolithiasis during ceftriaxone therapy Antimicrob Agents Chemother 34 1990 1146 1149
5. F. Papadopoulou, S. Efremidis, and S. Karyda Incidence of ceftriaxone-associated gallbladder pseudolithiasis Acta Paediatr 88 1999 1352 1355
6. A. Palanduz, I. Yalcin, and E. Tonguc Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children J Clin Ultrasound 28 2000 166 168
7. M.L. Shiffman, F.B. Keith, and E. Moore Pathogenesis of ceftriaxone-associated biliary sludge: in vitro studies of calcium-ceftriaxone binding and solubility Gastroenterology 99 1990 1772 1778
8. M.S. Kong, and C.Y. Chen Risk factors leading to ceftriaxone associated biliary pseudolithiasis in children Chang Gung Med J 19 1996 50 54
9. Teelmann K, Scharer K, Udaka K. Experimentelle toxikologie von ceftriaxone (Ro 13-9904, Rocephin), Ceftriaxone ein neus parenterales cephalosporin. In: Grieshaber R, editor. Proceedings of the Hahnenklee Symposium, September 1981. Basel, Switzerland: Roche, 1982, pp. 91-111.
10. U.B. Schaad, H. Tschappeler, and M.J. Lentze Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy Pediatr Infect Dis 5 1986 708 710
11. R). Hoffmann La Roche: Scientific Update, 1987.
12. P.P. Purdum III, M.L. Shiffman, and E.W. Moore In vivo studies of biliary ceftriaxone excretion and solubility in guinea pig hepatic bile J Lab Clin Med 120 1992 604 613
13. S.P. Lee, B.A. Lipsky, and S.A. Teefey Gallbladder sludge and antibiotics Pediatr Infect Dis J 9 1990 422 423